New Vivus board appoints Zook as CEO
This article was originally published in Scrip
Executive Summary
Former AstraZeneca commercial head Anthony "Tony" Zook was appointed CEO of obesity drug maker Vivus as expected now that the Mountain View, California-based company's largest investor First Manhattan Co (FMC) controls a majority of the Vivus board of directors seats.